Aqtual

PrognomiQ

This healthcare company develops multi-omics blood tests for the early detection and monitoring of cancer and complex diseases for clinical health systems.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

DETECTRA

This company develops a digital platform and AI algorithm to monitor joint inflammation through smartphone photos for patients with inflammatory arthritis and their rheumatologists.

PredictaMed

This company develops an AI platform for healthcare providers to identify at-risk patients and accelerate the diagnosis of autoimmune diseases.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

Septest

This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.

SurgeCare

The company develops AI-driven blood tests to predict postoperative infection risks for surgical teams and hospitals.